[5-amino-1-(4-fluorophenyl)-1H-pyrazol-4-yl][3-(piperidin-4-yloxy)phenyl]methanone

[5-amino-1-(4-fluorophenyl)-1H-pyrazol-4-yl][3-(piperidin-4-yloxy)phenyl]methanone is a synthetic small molecule belonging to the benzoylpyrazole class. It is structurally related to a series of compounds developed as selective inhibitors of mitogen-activated protein kinase 14 (MAPK14, also known as p38α MAP kinase), an enzyme involved in inflammatory signaling pathways. While closely related analogs have been studied for their anti-inflammatory and potential antineoplastic properties, this specific compound does not appear to be approved or advanced into clinical development and is primarily used in research settings[6][3]. Its mechanism of action is presumed to involve inhibition of MAPK14, thereby modulating cellular responses to pro-inflammatory cytokines such as interleukin 1, interleukin 6, and tumor necrosis factor alpha[3][6].